NCT00576108View on ClinicalTrials.gov

A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Postherpetic NeuralgiaShinglesHerpes ZosterNeuropathic Pain
Interventions
DRUG

KD7040 Topical Gel

KD7040 topical gel

DRUG

Placebo gel

Placebo gel

Trial Locations (1)

Unknown

United Bioscience Corporation, Kansas City

Sponsors

Lead Sponsor

Kalypsys, Inc.
All Listed Sponsors
lead

Kalypsys, Inc.

INDUSTRY